The Polymer Imperative: Why the Future of Structural Heart Devices Is Non-Metallic
Nitinol made the first generation of LAA occlusion possible. It should not define the second.
For decades, cardiovascular device design has been dominated by nitinol and rigid metallic frames. While nitinol enabled the first generation of minimally invasive Left Atrial Appendage (LAA) occlusion devices, metal in the heart comes with trade-offs: permanent tissue friction, risk of erosion, delayed endothelialization, and chronic local inflammatory response.
The next frontier of structural heart engineering lies in polymer-based bio-materials. By engineering polymers that match the compliance, stretch, and stress-strain profiles of native cardiac tissue, we can create occlusion implants that integrate seamlessly into the myocardial landscape. A compliant polymer structure accelerates tissue healing over the device face while eliminating the need for long-term anticoagulants.
As biomedical engineers, our goal shouldn't merely be plugging a structural anomaly; it must be designing implants that the human body accepts as native tissue.